Custom blood test could spot cancer return in head and neck patients
NCT ID NCT03896412
First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This study looked at whether a personalized blood test can find tiny bits of tumor DNA (ctDNA) in 40 people with advanced head and neck cancer. The test was tailored to each patient's unique tumor mutations. Researchers checked blood before surgery, after surgery, and for 18 months to see if ctDNA levels could predict cancer coming back. The goal is to better understand who needs more aggressive treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU
Rouen, 76000, France
-
Centre Henri Becquerel
Rouen, 76000, France
Conditions
Explore the condition pages connected to this study.